Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05119400 · ClinicalTrials.gov registry record
COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- 2
- Enrollment target
NCT05119400: Clinical Trial study, sponsored by Weill Medical College of Cornell University.
NCT05119400 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05119400 was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The goal of this longitudinal and observational study is to better understand the psychiatric consequences of COVID-19 over time. Psychiatric outcomes like mood, anxiety, stress, and cognitive symptoms in patients who underwent inpatient hospitalization at NewYork-Presbyterian Hospital/Weill Cornell Medicine for COVID-19 will be assessed at 6 months or later post-discharge.
Primary Outcome
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) comprises auditory and visual subtasks of attention, language, visuospatial/constructional abilities, and immediate and delayed memory. Each subtask is assessed as accuracy (number of correct responses) and subsequently combined into a composite score (RBANS Total Scale score).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-12-17 |
| Est. Completion | 2024-04-02 |
Why NCT05119400 stopped before completion
NCT05119400 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05119400 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05119400 about?
NCT05119400 is a clinical study titled "COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes". The goal of this longitudinal and observational study is to better understand the psychiatric consequences of COVID-19 over time. Psychiatric outcomes like mood, anxiety, stress, and cognitive symptoms in patients who underwent inpatient hospitalization at NewYork-Presbyterian Hospital/Weill Cornell...
What is the current status of trial NCT05119400?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2021-12-17. Estimated completion is 2024-04-02.
Who is sponsoring clinical trial NCT05119400?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI